Results 41 to 50 of about 2,582,050 (300)
Surgery in Epilepsy – How Advances in Human Neurology Can Benefit Veterinary Patients
Veterinary Evidence, 2016 This article reports the evidence behind pre-surgical evaluation and epilepsy surgery in human patients with drug-resistant idiopathic epilepsy and how this could potentially form the basis for the treatment of canine drug-resistant epilepsy in the ...
Marios Charalambous
doaj +1 more source
Ketogenic diets for drug-resistant epilepsy [PDF]
Cochrane Database of Systematic Reviews, 2018 Ketogenic diets (KDs), being high in fat and low in carbohydrates, have been suggested to reduce seizure frequency in people with epilepsy. At present, such diets are mainly recommended for children who continue to have seizures despite treatment with antiepileptic drugs (AEDs) (drug-resistant epilepsy).
Kirsty J, Martin-McGill +4 more
openaire +2 more sources
Frontiers in Pharmacology, 2021 One-third of patients with epilepsy suffer from drug-resistant epilepsy (DRE). Valproic acid (VPA) is a classic anticonvulsant drug, and its resistance is a crucial predictor of DRE, but the pathogenesis remain unknown.
Meng Fu +7 more
doaj +1 more source
Epilepsy and drug-resistant epilepsy in children with cerebral palsy: A retrospective observational study [PDF]
, 2020 Purpose: The objective of this study was to determine risk factors for epilepsy and drug-resistant epilepsy (DRE) development in children with cerebral palsy.
Dilek, Mustafa +3 more
core +1 more source
EXPLORING COGNITIVE IMPAIRMENTS IN DRUG-RESISTANT EPILEPSY: INSIGHTS FROM A COMPARATIVE ANALYSIS
Journal of Social SciencesThis article explores the cognitive impairments in individuals with drug-resistant epilepsy compared to those with well-controlled epilepsy. The research involves 102 subjects (62 with drug-resistant epilepsy and 40 with well-controlled epilepsy), and ...
DOTEN, Natalia
doaj +1 more source
Lacosamide in children with drug‐resistant epilepsy [PDF]
Journal of Paediatrics and Child Health, 2018 AimTo assess the effectiveness and tolerability of lacosamide in paediatric clinical practice.MethodsA search of our hospital's pharmacy database yielded all children <16 years old dispensed lacosamide for drug‐resistant epilepsy between January 2011 and June 2016. Medical records were reviewed for clinical and drug details. Continued treatment for ≥
Andrea D Rüegger +2 more
openaire +3 more sources
Frontiers in NeurologyAn increasing number of gene mutations associated with epilepsy have been identified, some linked to gray matter heterotopia—a common cause of drug-resistant epilepsy.
Zijian Li +5 more
doaj +1 more source
Evaluation of Risk Factors for Epilepsy in Pediatric Patients with Cerebral Palsy
Brain Sciences, 2020 Cerebral palsy (CP) is a set of etiologically diverse symptoms that change with the child’s age. It is one of the most frequent causes of motor disability in children. CP occurs at a frequency of 1.5 to 3.0 per 1000 live-born children.
Małgorzata Sadowska +2 more
doaj +1 more source
Explaining risk factors for drug-resistant tuberculosis in England and Wales: contribution of primary and secondary drug resistance [PDF]
, 2004 Drug-resistant tuberculosis can be transmitted (primary) or develop during the course of treatment (secondary). We investigated risk factors for each type of resistance.
Glynn, JR +5 more
core +1 more source
Immunoprofiling of drug-resistant epilepsy with a focus on glutamic acid decarboxylase 65 antibodies [PDF]
, 2022 The urgent need to improve therapies for people with drug-resistant epilepsy (DRE) requires improved understanding of the aetiopathophysiology of epilepsy and the mechanisms responsible for pharmacoresistance. Autoantibody-mediated processes may explain
McGinty, Ronan
core +1 more source